Stay updated on Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.

Latest updates to the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6. This indicates a minor administrative update to the site's version metadata rather than changes to study details.SummaryDifference0.0%

- Check13 days agoChange DetectedA new line '2015 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH funding for GS-US-296-1080.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, signaling a small document-level update rather than a content change.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page's revision indicator was updated to v3.6.4, replacing the previous v3.6.3. This signals a minor update to the page's metadata rather than a substantive change to its content.SummaryDifference0.0%

- Check70 days agoChange DetectedFooter revision tag updated to v3.6.3, replacing the previous v3.6.0 tag. This is a backend/documentation update and does not alter study page content or data.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page now indicates that no participants are being recruited for the GAMMA-1 study. This clarifies that enrollment has ended and helps users understand the current participation status.SummaryDifference0.2%

Stay in the know with updates to Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Andecaliximab mFOLFOX6 in Gastric Cancer Clinical Trial page.